These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 26213103

  • 1. Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease.
    van Laar T, Nyholm D, Nyman R.
    Acta Neurol Scand; 2016 Mar; 133(3):208-15. PubMed ID: 26213103
    [Abstract] [Full Text] [Related]

  • 2. Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease.
    Meppelink AM, Nyman R, van Laar T, Drent M, Prins T, Leenders KL.
    Mov Disord; 2011 Feb 01; 26(2):331-4. PubMed ID: 20960486
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
    Fernandez HH, Boyd JT, Fung VSC, Lew MF, Rodriguez RL, Slevin JT, Standaert DG, Zadikoff C, Vanagunas AD, Chatamra K, Eaton S, Facheris MF, Hall C, Robieson WZ, Benesh J, Espay AJ.
    Mov Disord; 2018 Jul 01; 33(6):928-936. PubMed ID: 29570853
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.
    Antonini A, Fung VS, Boyd JT, Slevin JT, Hall C, Chatamra K, Eaton S, Benesh JA.
    Mov Disord; 2016 Apr 01; 31(4):530-7. PubMed ID: 26817533
    [Abstract] [Full Text] [Related]

  • 9. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience.
    Zibetti M, Merola A, Artusi CA, Rizzi L, Angrisano S, Reggio D, De Angelis C, Rizzone M, Lopiano L.
    Eur J Neurol; 2014 Feb 01; 21(2):312-8. PubMed ID: 24313838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease].
    Santos-Garcia D, de Deus T, Lopez-Pazos E, Macias-Arribi M, Llaneza-Gonzalez MA, Echarri-Piudo A, Carpintero P, de la Fuente-Fernandez R.
    Rev Neurol; 2014 Jun 01; 58(11):505-15. PubMed ID: 24861226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.